Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Patent
1997-09-25
1999-09-28
Ketter, James
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
4353201, 514 44, 536 2372, A61K 39255
Patent
active
059584254
ABSTRACT:
A vaccine effective against Marek's disease virus (MDV) comprises (a) an MDV attenuated by virtue of being TK- or (b) a host expressing an MDV antigen, namely the respective MDV homologues of the HSV gB, gC, gD or gH glycoproteins (or antigenic parts thereof) or the respective MDV homologues of the HSV-1 immediate early genes IE-68 or IE-175. The host may be a herpes virus of turkeys (HVT), more particularly HVT in which the MDV antigen is inserted in the HVT homologue of the HSV gC gene, the ribonucleotide reductase (large subunit) gene or the thymidine kinase (TK) gene.
Binns Matthew McKinley
Ross Louis Joseph Norman
Scott Simon David
Ketter James
Rhone Merieux
LandOfFree
Viral vaccines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Viral vaccines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Viral vaccines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-700230